Drugs / BNO 1016
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01706484 | Sep 2012 → Apr 2014 | chronic rhinosinusitis | Bionorica SE | Completed | No outcome recorded |
| Phase 3 | NCT01146860 | Jan → Apr 2010 | sinusitis | Bionorica SE | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNO 1016 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01146860 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “A herbal drug combination (Dry Extract BNO 1016) has been assessed for efficacy and tolerability in patients with acute viral rhinosinusitis.” PMID 23193534 ↗ Dec 2012 |
| Route | Oral | “BNO 1016 or placebo (coated tablets administered orally).” PMID 23193534 ↗ Dec 2012 |